A Phase Ⅰ/Ⅱa Study of HMPL-A251 in Participants With Advanced or Metastatic HER2-expressing Solid Tumors
A Phase Ⅰ/Ⅱa Study of HMPL-A251 in Participants With Advanced or Metastatic HER2-expressing Solid Tumors
Recruiting · NCT07228247 · Registry updated 2026-09-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase Ⅰ/Ⅱa Study of HMPL-A251 in Participants With Advanced or Metastatic HER2-expressing Solid Tumors | Solid Tumors, Adult | Recruiting | Phase 1 / Phase 2 | 2026-09-22 | NCT07228247 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hutchmed | 13 |
15 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| BRCR Global | Plantation | United States | 12 |
| Cleveland Clinic Taussig Cancer Center | Cleveland | United States | 16 |
| Florida Clinical Trials Group LLC (Plantation) | Plantation | United States | 1 |
| Florida Clinical Trials Group LLC (Tamarac) | Tamarac | United States | 1 |
| Fudan University Shanghai Cancer Center | Shanghai | China | 128 |
| Henan Cancer Hospital | Zhengzhou | China | 60 |
| Hunan Cancer Hospital | Changsha | China | 47 |
| Memorial Sloan Kettering Cancer Center | New York | United States | 1000 |
| Northwest Medical Specialties, PLLC | Tacoma | United States | 29 |
| Peking University First Hospital | Beijing | China | 72 |
| SCRI HealthONE | Denver | United States | 2 |
| START New Jersey | East Brunswick | United States | 16 |
| Sun Yat-Sen University Cancer Center | Guangzhou | China | 66 |
| The First Affiliated Hospital of Anhui Medical University | Hefei | China | 28 |
| The First Hospital of China Medical University | Shenyang | China | 22 |